Carrier-mediated transport of the antitumor agent acivicin across the blood-brain barrier
- 30 March 1995
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 49 (7) , 941-945
- https://doi.org/10.1016/0006-2952(95)00005-k
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Hydrogen Bonding Potential as a Determinant of the in Vitro and in Situ Blood–Brain Barrier Permeability of PeptidesPharmaceutical Research, 1994
- Affinity of antineoplastic amino acid drugs for the large neutral amino acid transporter of the blood-brain barrierCancer Chemotherapy and Pharmacology, 1991
- Kinetics of Neutral Amino Acid Transport Across the Blood‐Brain BarrierJournal of Neurochemistry, 1987
- Characteristics of the Large Neutral Amino Acid Transport System of Bovine Brain Microvessel Endothelial Cell MonolayersJournal of Neurochemistry, 1986
- Kinetic analysis ofl-leucine transport across the blood-brain barrierBrain Research, 1984
- Phase I evaluation of AT-125 single dose every three weeksInvestigational New Drugs, 1984
- Brain metabolism: a perspective from the blood-brain barrierPhysiological Reviews, 1983
- Studies of the biochemical pharmacology of the fermentation-derived antitumor agent, (αS, 5S) -α-amino-3-chloro-4, 5-dihydro-5-isoxazoleacetic acid (at-125)Advances in Enzyme Regulation, 1979
- Improved delivery through biological membranes. 4. Prodrugs of L-DOPAJournal of Medicinal Chemistry, 1977
- Amino acid assignment to one of three blood-brain barrier amino acid carriersAmerican Journal of Physiology-Legacy Content, 1976